Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Pemvidutide

RECLAIM STUDY: Phase 2 Study of the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol Use Disorder (AUD) in Subjects With Obesity or Overweight

Altimmune · Phase 2 · Completed · Enrollment 100

NCT06987513

ArmPopulationDoseWeeksEstimandWeight change
Pemvidutide 2.4 mgAlcohol Use Disorder (AUD)2.4 mgn/rn/rn/r
PlaceboAlcohol Use Disorder (AUD)n/rn/rn/rn/r